Advertisement

Biochemistry (Moscow)

, Volume 79, Issue 12, pp 1371–1375 | Cite as

Cytokine profile in children with inflammatory bowel disease

  • A. P. ToptyginaEmail author
  • E. L. Semikina
  • G. V. Bobyleva
  • L. V. Miroshkina
  • S. V. Petrichuk
Article

Abstract

Crohn’s disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) characterized by immune reactivity against microbial and auto-antigens. This work was designed to study the cytokine profile in blood serum and coproextracts of children with CD and UC. The studied patients consisted of 17 children with CD (group I), 17 children with UC (group II), and 18 controls with intestinal dysbiosis (group III). The diagnosis of UC and CD was based on accepted clinical and endoscopic criteria. The levels of 13 cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, IL-17A, TNF-α, TGF-β, and IFN-γ) were determined in blood sera and coproextracts of the patients and controls using the BioPlex technology. The level of IL-17A was significantly increased and that of TGF-β was significantly decreased in the blood serum of the patients with IBDs. Changes in the cytokine profile in the coproextracts affected the wider spectrum of cytokines. The levels of proinflammatory cytokines (IL-2, IL-4, IL-6, IL-12p70, TNF-α, and IFN-γ) were increased 6–9-fold, whereas the level of the anti-inflammatory cytokine IL-10 was increased 3-fold. The cytokine balance was shifted to the proinflammatory cytokines. The TGF-β level was increased 9-fold and that of IL-17A was increased 3-fold. Thus, the cytokine profile in the coproextracts was more informative than that of the blood serum. The determination of cytokines in coproextracts is simple and noninvasive.

Key words

cytokines interleukin Crohn’s disease ulcerative colitis children 

Abbreviations

CD

Crohn’s disease

IBD

inflammatory bowel disease

Th

T-helpers

UC

ulcerative colitis

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yablokova, E. A., Gorelov, A. V., Ratnikova, M. A., Sichinava, I. V., Grammatopulo, M. I., Polotnyanko, E. Yu., and Borisova, E. V. (2006) Inflammatory bowel disease in children, Pediatriya, 5, 99–102.Google Scholar
  2. 2.
    Abraham, C., and Medzhitov, R. (2011) Interactions between the host innate immune system and microbes in inflammatory bowel disease, Gastroenterology, 140, 1729–1737.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Hansen, R., Thomson, J. M., El-Omar, E. M., and Hold, G. L. (2010) The role of infection in the aetiology of inflammatory bowel disease, J. Gastroenterol., 45, 266–276.PubMedCrossRefGoogle Scholar
  4. 4.
    Kaur, N., Chen, C. C., Luther, J., and Kao, J. Y. (2011) Intestinal dysbiosis in inflammatory bowel disease, Gut Microbes, 2, 211–216.PubMedCrossRefGoogle Scholar
  5. 5.
    Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., and Pace, N. R. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proc. Natl. Acad. Sci. USA, 104, 13780–13785.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Sokol, H., Seksik, P., Rigottier-Gois, L., Lay, C., Lepage, P., Podglajen, I., Marteau, P., and Dore, J. (2006) Specificities of the fecal microbiota in inflammatory bowel disease, Inflamm. Bowel Dis., 12, 106–111.PubMedCrossRefGoogle Scholar
  7. 7.
    Neut, C., Bulois, P., Desreumaux, P., Membre, J. M., Lederman, E., Gambiez, L., Cortot, A., Quandalle, P., van Kruiningen, H., and Colombel, J. F. (2002) Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn’s disease, Am. J. Gastroenterol., 97, 939–946.PubMedCrossRefGoogle Scholar
  8. 8.
    Andoh, A., Kuzuoka, H., Tsujikawa, T., Nakamura, S., Hirai, F., Suzuki, Y., Matsui, T., Fujiyama, Y., and Matsumoto, T. (2012) Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease, J. Gastroenterol., 47, 1298–1307.PubMedCrossRefGoogle Scholar
  9. 9.
    Mukhopadhya, I., Hansen, R., El-Omar, E. M., and Hold, G. L. (2012) IBD-what role do Proteobacteria play? Nat. Rev. Gastroenterol. Hepatol., 9, 219–230.PubMedCrossRefGoogle Scholar
  10. 10.
    Simms, L. A., Doecke, J. D., Walsh, M. D., Huang, N., Fowler, E. V., and Radford-Smith, G. L. (2008) Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn’s disease, Gut, 57, 903–910.PubMedCrossRefGoogle Scholar
  11. 11.
    Abraham, C., and Cho, J. H. (2009) Inflammatory bowel disease, N. Engl. J. Med., 361, 2066–2078.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Sanchez-Munoz, F., Dominguez-Lopez, A., and Yamamoto-Furusho, J. K. (2008) Role of cytokines in inflammatory bowel disease, World J. Gastroenterol., 14, 4280–4288.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C., and Strober, W. (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5, J. Immunol., 157, 1261–1270.PubMedGoogle Scholar
  14. 14.
    Bamias, G., Nyce, M. R., De La Rue, S. A., and Cominelli, F. (2005) New concepts in the pathophysiology of inflammatory bowel disease, Ann. Intern. Med., 143, 895–904.PubMedCrossRefGoogle Scholar
  15. 15.
    Elgbratt, K., Kurlberg, G., Hahn-Zohric, M., and Hultgren Hornquist, E. (2010) Rapid migration of thymic emigrants to the colonic mucosa in ulcerative colitis patients, Clin. Exp. Immunol., 162, 325–336.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Fina, D., and Pallone, F. (2008) What is the role of cytokines and chemokines in IBD? Inflamm. Bowel Dis., 14, 117–118.CrossRefGoogle Scholar
  17. 17.
    Muzes, G., Molnar, B., Tulassay, Z., and Sipos, F. (2012) Changes of the cytokine profile in inflammatory bowel diseases, World J. Gastroenterol., 18, 5848–5861.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Ostanin, A. A., and Chernykh, E. P. (2005) Comparative assessment of the level of 17 cytokines in serum and blood of healthy donors using flow fluorimetry, Tsitokiny Vospalenie, 4, 25–32.Google Scholar
  19. 19.
    Toptygina, A. P., and Aleshkin, V. A. (2011) Production of cytokines in intact children and children vaccinated with the Priorix vaccine in response to stimulation by measles and rubella virus antigens, Immunologiya, 32, 200–205.Google Scholar
  20. 20.
    Shen, W., and Durum, S. K. (2010) Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease, Neurochem. Res., 35, 940–946.PubMedCrossRefGoogle Scholar
  21. 21.
    Ito, R., Kita M., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Iwakura, Y., Okanoue, T., Yoshikawa, T., Kataoka, K., and Mazda, O. (2008) Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice, Biochem. Biophys. Res. Commun., 377, 12–16.PubMedCrossRefGoogle Scholar
  22. 22.
    Fahlen, L., Read, S., Gorelik, L., Hurst, S. D., Coffman, R. L., Flavell, R. A., and Powrie, F. (2005) T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells, J. Exp. Med., 201, 737–746.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Miroshkina, L. V., Petrichuk, S. V., Tsimbalova, E. G., Potapov, A. S., Venediktova, M. M., Toptygina, A. P., Kurbatova, O. V., Izmailova, T. D., Semikina, E. L., and Varichkina, M. A. (2013) Cytokine profile in children with inflammatory bowel diseases as a predictor of efficiency of therapy with infliximab, Vopr. Diagnost. Pediatr., 5, 33–38.Google Scholar
  24. 24.
    Toptygina, A. P., Bobyleva, G. V., and Aleshkin, V. A. (2008) Correlation between mucosal and systemic immune responses in infants, Ros. Immunol. Zh., 2, 449–453.Google Scholar
  25. 25.
    Nielsen, O. H., Kirman, I., Rudiger, N., Hendel, J., and Vainer, B. (2003) Upregulation of interleukin-12 and -17 in active inflammatory bowel disease, Scand. J. Gastroenterol., 38, 180–185.PubMedCrossRefGoogle Scholar
  26. 26.
    Sakuraba, A., Sato, T., Kamada, N., Kitazume, M., Sugita, A., and Hibi, T. (2009) Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn’s disease, Gastroenterology, 137, 1736–1745.PubMedCrossRefGoogle Scholar
  27. 27.
    Shalapour, S., Deiser, K., Kuhl, A. A., Glauben, R., Krug, S. M., Fischer, A., Sercan, O., Chappaz, S., Bereswill, S., Heimesaat, M. M., Loddenkemper, C., Fromm, M., Finke, D., Hammerling, G. J., Arnold, B., Siegmund, B., and Schuler, T. (2012) Interleukin-7 links T lymphocyte and intestinal epithelial cell homeostasis, PLoS One, 7, e31939.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Xavier, R. J., and Podolsky, D. K. (2007) Unravelling the pathogenesis of inflammatory bowel disease, Nature, 448, 427–434.PubMedCrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2014

Authors and Affiliations

  • A. P. Toptygina
    • 1
    • 2
    Email author
  • E. L. Semikina
    • 3
    • 4
  • G. V. Bobyleva
    • 1
  • L. V. Miroshkina
    • 3
  • S. V. Petrichuk
    • 3
  1. 1.Gabrichevsky Institute of Epidemiology and MicrobiologyMoscowRussia
  2. 2.Faculty of BiologyLomonosov Moscow State UniversityMoscowRussia
  3. 3.Scientific Center of Children HealthRussian Academy of Medical SciencesMoscowRussia
  4. 4.Pirogov Russian National Research Medical UniversityMoscowRussia

Personalised recommendations